ConductScience.org, home

Trial · NCT00399893

Outcomes11

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Decrease in Fasting Total Ghrelin6 monthsDescriptive statistics or percent of change from the baseline for the 5 patients was used.~A patient withdrew but included in analysis.ParticipantsNUMBER
SECONDARYNumber of Participants With Decreased Body Composition From Baseline to 6 Months by BOD POD®6 monthsParticipant withdrew but data was used for analysisparticipantsNUMBER
PRIMARYNumber of Participants With Decrease in Weight From Baseline to 6 Months6 monthsparticipantsNUMBER
PRIMARYNumber of Participants With Decreased BMI Z-score From Baseline to 6 Months6 monthsA participant withdrew but was included in analysisparticipantsNUMBER
PRIMARYNumber of Participants With Decreased Skin-fold Measurements From Baseline to 6 Months6 months
The skin fold measurements were performed; however, the data was not completed in a manner that could be analyzed; therefore we could not analyze the data. Completed data is not available to complete this outcome.
PRIMARYNumber of Participants With Decrease in Hunger and Food Intake6 monthsFor this outcome measure, data from questionnaires and forms was not completed. Data for all questionnaires is not available to report.
SECONDARYNumber of Participants With Decreased Body-composition From Baseline to 6 Months by DEXA6 monthsData for this outcome was not analyzedparticipantsNUMBER
PRIMARYNumber of Participants With Improved Insulin Regulation From Baseline to 6 Months6 monthsParticipant withdrew but was used in the data analysisparticipantsNUMBER
PRIMARYNumber of Participants With Improved Adiponectin Regulation From Baseline to 6 Months6 monthsA participant withdrew but data was used for analysisparticipantsNUMBER
PRIMARYNumber of Participants With Improved Leptin Regulation From Baseline to 6 Months6 monthsparticipantsNUMBER
PRIMARYNumber of Participants With Improved Peptide YY (PYY) Regulation From Baseline to 6 Months6 monthsParticipant withdrew but data was used for analysisparticipantsNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00399893/outcomes